The estimated Net Worth of John D Jr Stobo is at least $947 Tysiąc dollars as of 8 February 2006. John Stobo owns over 66,041 units of Omnicell stock worth over $906,236 and over the last 21 years John sold OMCL stock worth over $40,938.
John has made over 2 trades of the Omnicell stock since 2004, according to the Form 4 filled with the SEC. Most recently John exercised 66,041 units of OMCL stock worth $235,766 on 8 February 2006.
The largest trade John's ever made was exercising 66,041 units of Omnicell stock on 8 February 2006 worth over $235,766. On average, John trades about 8,546 units every 93 days since 2003. As of 8 February 2006 John still owns at least 21,041 units of Omnicell stock.
You can see the complete history of John Stobo stock trades at the bottom of the page.
John's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps oraz Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: